Antimicrobial activity of gentamicin and vancomycin combination in joint fluids after antibiotic-loaded cement spacer implantation in two-stage revision surgery

Journal of Chemotherapy

Volumn 27, Issue 1, 2015, Pages 17-24

  Minelli, Elisa Bertazzoni ^a   Benini, Anna ^a   Samaila, Elena ^a   Bondi, Manuel ^a   Magnan, Bruno ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Antibiotic combination; Bactericidal titer; Drug delivery system; Polymethylmethacrylate (PMMA) bone cement; Prosthetic infections; Spacer implantation in vivo; Synergism

Indexed keywords

BONE CEMENT; CEFAZOLIN; GENTAMICIN; POLY (METHYL METHACRYLATE); UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; POLY(METHYL METHACRYLATE);

ABSENCE OF SIDE EFFECTS; ADULT; ANTIMICROBIAL ACTIVITY; ARTHROPLASTY; ARTICLE; BONE SCINTISCANNING; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HEMOLYTIC STREPTOCOCCUS; HUMAN; IMPLANTATION; JOINT ASPIRATION; JOINT BIOPSY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; ORTHOPEDIC ENDOPROSTHESIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SYNOVIAL FLUID; AGED; CHEMISTRY; DRUG EFFECTS; DRUG POTENTIATION; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; PROSTHESIS-RELATED INFECTIONS; REOPERATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BONE CEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; FEMALE; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; POLYMETHYL METHACRYLATE; PROSTHESIS-RELATED INFECTIONS; REOPERATION; VANCOMYCIN;

EID: 84920517818     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947813Y.0000000157     Document Type: Article

References (28)

1. Diefenbeck M, Mückley T, Hofmann GO. Prophylaxis and treatment of implant-related infections by local application of antibiotics. Injury. 2006;37(Suppl 2):S95–104.
2. Moran E, Byren I, Atkins BL. The diagnosis and management of prosthetic joint infections. J Antimicrob Chemother. 2010;65(Suppl 3):iii45–54.
3. Lee J, Kang CI, Lee JH, Joung M, Moon S, Wi YM, et al. Risk factors for treatment failure in patients with prosthetic joint infections. J Hosp Infect. 2010;75:273–76.
4. Gonzales Della Valle A, Bostrom M, Brause B, Harney C, Salvati EA. Effective bactericidal activity of tobramycin and vancomycin eluted from acrylic bone cement. Acta Orthop Scand. 2001;72:237–40.
5. Kelm J, Regitz T, Schmitt E, Jung W, Anagnostakos K. In vivo and in vitro studies of antibiotic release from and bacterial growth inhibition by antibiotic-impregnated polymethylmethacrylate hip spacers. Antimicrob Agents Chemother. 2006;50:332–5.
6. Mutimer J, Gillespie G, Lovering AM, Porteous AJ. Measurements of in vivo intra-articular gentamicin levels from antibiotic loaded articulating spacers in revision total knee replacement. Knee. 2009;16:39–41.
7. Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta Orthop. 2009;80:193–7.
8. Bertazzoni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;53:329–34.
9. Greidanus NV, Masri BA, Garbuz DS, Wilson SD, McAlinden MG, Xu M, et al. Use of erythrocyte sedimentation rate and Creactive protein level to diagnose infection before revision total knee arthroplasty. J Bone Joint Surg Am. 2007;89:1409–16.
10. Fuster D, Soriano A, Garcia S, Piera C, Suades J, Rodríguez D, et al. Usefulness of 99mTc-ciprofloxacin scintigraphy in the diagnosis of prosthetic joint infections. Nucl Med Commun. 2011;32:44–51.
11. Iyengar KP, Vinjamuri S. Role of 99mTc Sulesomab in the diagnosis of prosthetic joint infections. Nucl Med Commun. 2005;26:489–96.
12. Ghanem E, Parvizi J, Burnett RS, Sharkey PF, Keshavarzi N, Aggarwal A, et al. Cell count and differential of aspirated fluid in the diagnosis of infection at the site of total knee arthroplasty. J Bone Joint Surg Am. 2008;90:1637–43.
13. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically – eighth edition: approved standard M07-A8. Wayne, PA, USA: CLSI; 2009.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: nineteenth informational supplement M100-S19. Wayne, PA, USA: CLSI; 2009.
15. Eliopoulos GM, Moellering RC. Antimicrobial combination. In: Lorian V, editor. Antibiotics in laboratory medicine, 4th edn. Baltimore, MD: Williams & Wilkins; 1996. p. 330–96.
16. Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In: Lorian V, editor. Antibiotics in laboratory medicine, 4th edn. Baltimore, MD: Williams & Wilkins; 1996. p. 52–111.
17. Wu P, Grainger DW. Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials. 2006;27: 2450–67.
18. Fink B, Vogt S, Reinsch M, Bu¨chner H. Sufficient release of antibiotic by a spacer 6 weeks after implantation in two-stage revision of infected hip prostheses. Clin Orthop Relat Res. 2011;469:3141–7.
19. Gyssens IC. Vancomycin. In: Grayson ML, editor. Kucers’ the use of antibiotics, 6th edition. London: Hodder Arnold; 2010. p. 569–600.
20. EUCAST Disk Diffusion Test for Routine Antimicrobial Susceptibility Testing. [document on the Internet]. Available from: http://www.eucast.org/clinical_breakpoints/ (last accessed (text modified) 2013 April 29).
21. Ueng SW, Hsieh PH, Shih HN, Chan YS, Lee MS, Chang Y. Antibacterial activity of joint fluid in cemented total-knee arthroplasty: an in vivo comparative study of polymethylmethacrylate with and without antibiotic loading. Antimicrob Agents Chemother. 2012;56:5541–6.
22. Bertazzoni Minelli E, Benini A, Bassi C, Abbas H, Falconi M, Locatelli F, et al. Antimicrobial activity of human pancreatic juice and its interaction with antibiotics. Antimicrob Agents Chemother. 1996;40:2099–105.
23. Bertazzoni Minelli E, Della Bora T, Benini A. Different microbial biofilm formation on polymethylmethacrylate (PMMA) bone cement loaded with gentamicin and vancomycin. Anaerobe. 2011;17:380–3.
24. Zimmerli W, Trampuz A. Implant-associated infection. In: Bjarnsholt T, Moser C, Jense PO, Høiby N, editors. Biofilm infections. New York, NY: Springer; 2011. p. 69–90.
25. Phillips JE, Crane TP, Noy M, Elliott TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15–year prospective survey. J Bone Joint Surg Br. 2006;88:943–8.
26. Baleani M, Traina F, Toni A. The mechanical behaviour of a preformed hip spacer. Hip Int. 2003;13:159–62.
27. Villa T, Carnelli D. Experimental evaluation of the biomechanical performances of a PMMA-based knee spacer. Knee. 2007;14:145–53.
28. Magnan B, Regis D, Costa A, Bartolozzi P. Two-stage revision of infected total hip replacement using a preformed, antibiotic-loaded acrylic cement spacer. In: Meani E, Romanó CL, Crosby L, Hofmann G, editors. Infection and local treatment in orthopedic surgery. Berlin: Springer-Verlag; 2007. p. 205–13.